Exelixis (EXEL) Tops Q4 EPS by 16c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $54.08 --0%
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
SQZB, RENO, LUNA, More
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
SQZB, RENO, LUNA, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.55, $0.16 better than the analyst estimate of $0.39. Revenue for the quarter came in at $566.8 million versus the consensus estimate of $559.89 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.15-2.25 billion, versus the consensus of $2.251 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
- H.C. Wainwright Starts Inhibrx Biosciences (INBX) at Buy
- Humana (HUM) PT Raised to $450 at Wolfe Research
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
